Klint, S., Feldwisch, J., Gudmundsdotter, L., Bergstedt, K. D., Gunneriusson, E., Guthenberg, I. H., . . . Frejd, F. Y. (2023). Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis. Taylor & Francis Group.
Chicago Style (17th ed.) CitationKlint, Susanne, et al. Izokibep: Preclinical Development and First-in-human Study of a Novel IL-17A Neutralizing Affibody Molecule in Patients with Plaque Psoriasis. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationKlint, Susanne, et al. Izokibep: Preclinical Development and First-in-human Study of a Novel IL-17A Neutralizing Affibody Molecule in Patients with Plaque Psoriasis. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.